Role of phosphorylation in p53 acetylation and PAb421 epitope recognition in baculoviral and mammalian expressed proteins

FEBS Journal

Volumn 272, Issue 7, 2005, Pages 1669-1675

  Warnock, Lorna J ^a   Raines, Sally A ^a   Mee, Trevor R ^a   Milner, Jo ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Acetylation; p53 protein; PAb421 epitope; Phosphorylation

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; PAB421 EPITOPE; PROTEIN P53; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACULOVIRUS; ESCHERICHIA COLI; IMMUNOPRECIPITATION; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; WESTERN BLOTTING;

ACETYLATION; ANIMALS; ANTIBODIES; BACULOVIRIDAE; EPITOPES; GENETIC VECTORS; LYSINE; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; RECOMBINANT PROTEINS; SERINE; SPODOPTERA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17144378966     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04589.x     Document Type: Article

References (31)

1. Ljungman M (2000) Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress. Nat Neoplasia 2, 208-225.
2. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH & Levine AJ (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14, 981-993.
3. Haupt Y, Robles AI, Prives C & Rotter V (2002) Deconstruction of p53 functions and regulation. Oncogene 21, 8223-8231.
4. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD & Berger SL (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8, 1243-1254.
5. Brooks CL & Gu W (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15, 164-171.
6. Xu Y (2003) Regulation of p53 responses by post-translational modifications. Cell Death Differ 10, 400-403.
7. Xirodimas DP, Saville MK, Bourdon JC, Hay RT & Lane DP (2004) Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118, 83-97.
8. Bode AM & Dong Z (2004) Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4, 793-805.
9. Saito S, Goodarzi AA, Higashimoto Y, Noda Y, Lees-Miller SP, Appella E & Anderson CW (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionising radiation. J Biol Chem 277, 12491-12494.
10. Appella E & Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268, 2764-2772.
11. ARF contribution to the regulation of mutant p53 stability. Mol Cell Biol 21, 2743-2754.
12. Ito A, Lai C-H, Saito S, Hamilton MH, Appella E & Tao T-P (2001) p300/CBP-mediated acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20, 1331-1340.
13. Prives C & Manley JL (2001) Why is p53 acetylated? Cell 107, 815-818.
14. Wang YH, Tsay YG, Tan BC, Lo WY & Lee SC (2003) Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J Biol Chem 278, 25568-25576.
15. Warnock LJ & Raines SA (2004) Restoration of wild-type conformation to full-length and truncated p53 proteins. Cancer Biol Ther 3, 634-637.
16. Davidson TS, Nie X, Ma W, Lin Y, Kay C, Benchimol S & Arrowsmith CH (2001) Structure and functionality of a designed p53 dimer. J Mol Biol 307, 605-617.
17. Colman MS, Afshari. CA & Barrett JC (2000) Regulation of p53: stability and activity in response to genotoxic stress. Mut Res 462, 179-188.
18. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R & Brady JN (1998) Phosphorylation of p53 at serine 15 increases interaction with CBP. J Biol Chem 273, 33047-33053.
19. Saito S, Yamagichi H, Higashimoto Y, Chao C, Xu Y, Fornace AJ Jr, Appella E & Anderson CW (2003) Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 278, 37536-37544.
20. Mujtaba S, He Y, Zeng L, Yan S, Plotnikova O, Sachchidanand Sanchez R, Zeleznik-Le NJ, Ronai Z & Zhou MM (2004) Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell 13, 251-263.
21. 1 cyclin-dependent kinases. Nature 376, 88-91.
22. Kouzarides T (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO J 19, 1176-1179.
23. Harlow E, Crawford LV, Pim DC & Williamson NH (1981) Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol 39, 861-869.
24. Hupp TR, Meek DW, Midgley CA & Lane DP (1992) Regulation of the specific DNA binding function of p53. Cell 71, 875-886.
25. Takenaka I, Morin F, Seizinger BR & Kley N (1995) Regulation of the sequence-specific DNA-binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem 270, 5405-5411.
26. Luo J, Li. M, Tang Y, Laszkowska M, Roeder RG & Gu W (2004) Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101, 2259-2264.
27. Mee TR, Okorokov AL, Metcalfe S & Milner J (1999) Proteolytic cleavage of p53 mutants in response to mismatched DNA. Br J Cancer 81, 212-218.
28. Okorokov AL, Warnock L & Milner J (2002) Effect of wild-type, S15D and R175H p53 proteins on DNA end joining in vitro: potential mechanism of DNA double-strand break repair modulation. Carcinogenesis 23, 549-557.
29. Jiang M & Milner J (2003) Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev 17, 832-837.
30. Cook A & Milner J (1990) Evidence for allosteric variants of wild-type p53, a tumour suppressor protein. Br J Cancer 61, 548-552.
31. Milner J & Medcalf EA (1991) Cotranslation of activated mutant p53 with wild type drives the wild type p53 protein into the mutant conformation. Cell 65, 765-774.